Senzer offers meaningful medical advances in areas of healthcare where the need remains unmet or where an acute condition is unresponsive to conventional treatments.
By combining regulated cannabinoid therapies with our unique inhalation technologies, we can bring safe, reliable and quick relief to patients who live with cancer and those who endure chronic pain. With more effective treatment come better clinical outcomes.
Senzer’s next generation inhalation technology has produced one of the first pharmaceutical inhalers capable of effectively delivering systemic medication. Our proprietary novel inhalation technology and cannabinoid formulations are unique and provide significant clinical and commercial advantages.
Underpinned by more than 330 granted patents and design rights worldwide, our technology platform has the potential for many applications in the regulated pharmaceutical market. We continue to build on our success, investing in scientific and technical excellence to develop and launch a diverse pipeline of propriety branded products and systemic treatments for the regulated pharmaceutical market.
